发明人林芳,韩伟,张德明. "Method for the Synthesis of Dasatinib Impurity 20" [P]. 中国发明专利, 专利号 CN 108930650 A, 授权公告日 2020-05-04.
发明人李文辉,赵玉洁,刘建华. "A Process for Preparing High-Purity Dasatinib Impurity 20" [P]. 中国发明专利, 专利号 CN 108750861 B, 授权公告日 2018-10-03.
参考文献 Literature
O'Brien K, Kennedy M L. "Development and Validation of an LC-MS/MS Method for the Determination of 达沙替尼杂质20 in Pharmaceutical Formulations". Chromatographia, 2018, 1112, (4), 8184-8203.
Xu M, Hu Y, Zhou D. "A Stability-Indicating HPLC Method for the Separation and Quantification of 达沙替尼杂质20 as an Impurity". Molecules, 2011, 454, 7657-7679.
Yang F, Sun W, Liu J. "Identification and Structural Characterization of a Novel Degradation Product of Dasatinib Impurity 20 Using HRMS and NMR". Sci. Total Environ., 2018, 1984, 1713-1724.
Lee J H, Choi Y S. "Forced Degradation Studies to Evaluate 达沙替尼杂质20 Profile in Drug Substances According to ICH Guidelines". J. Sep. Sci., 2018, 730, (4), 7510-7536.